Sanguine
Bridging the gap between patients and researchers
About Sanguine
At Sanguine, our mission is to accelerate translational biomedical research by removing the barriers to patient participation. Through transparent communications, respectful patient support, and appropriate compensation, we keep patients engaged in the research process for a better patient experience and more impactful research biospecimens.
Company Facts
- Headquarters
- Woburn
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00101_00250
- Total Funding
- $12,224,981
- Last Funding Type
- debt_financing
- Last Funding Date
- 2023-10-31
- Website
- sanguinebio.com
Industries & Categories
Apps, Biotechnology, Clinical Trials, Health Care, Life Science, Medical
Social Links
Canonical: https://fsome.com/organization/sanguine-111274 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.